Compound information
- Natural Products
- ZC2964785
- Molecular Formula
- C26H22FN7O3
- Molecular Weight
- 499.176815784 g/mol
- Structure
-
- IUPAC Name
- 4-[4-[[5-fluoro-4-[3-(prop-2-enoylamino)anilino]pyrimidin-2-yl]amino]phenoxy]-N-methyl-pyridine-2-carboxamide
- InChI
- InChI=1S/C26H22FN7O3/c1-3-23(35)31-17-5-4-6-18(13-17)32-24-21(27)15-30-26(34-24)33-16-7-9-19(10-8-16)37-20-11-12-29-22(14-20)25(36)28-2/h3-15H,1H2,2H3,(H,28,36)(H,31,35)(H2,30,32,33,34)
- InChI Key
- VVLHQJDAUIPZFH-UHFFFAOYSA-N
- SMILES
- C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(Oc4ccnc(C(=O)NC)c4)cc3)ncc2F)c1
- Source
- ZINC000072317469
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 37 | Ring Count | 4 |
Heteroatom Count | 11 | Rotatable Bond Count | 9 |
Hydrogen Bond Acceptor Count | 8 | Hydrogen Bond Donor Count | 4 |
Topological Polar Surface Area | 130.16 Å2 | LogP | 4.197 |
LogS | -4.963 | LogD | 3.612 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.105 | Pgp substrate | 0.021 |
HIA | 0.948 | F20 % | 0.949 |
F30 % | 0.026 | Caco-2 | -5.216 |
MDCK | -5.523 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.077 | PPB | 95.427 |
VD | 1.105 | Fu | 2.182 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.99 | CYP1A2 substrate | 0.623 |
CYP2A6 substrate | 0.229 | CYP2B6 substrate | 0.576 |
CYP2C19 inhibitor | 0.63 | CYP2C19 substrate | 0.897 |
CYP2C8 substrate | 0.869 | CYP2C9 inhibitor | 0.207 |
CYP2C9 substrate | 0.881 | CYP2D6 inhibitor | 0.938 |
CYP2D6 substrate | 0.76 | CYP2E1 substrate | 0.134 |
CYP3A4 inhibitor | 0.879 | CYP3A4 substrate | 0.683 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.524 | CL | 4.348 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.144 | Hepatotoxicity | 0.997 |
Mutagenicity | 0.09 | Rat Oral Acute Toxicity | 0.033 |
FDAMDD | 0.953 | Skin Sensitization | 0.915 |
Carcinogenicity | 0.163 | Eye Corrosion | 0.004 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.971 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 1.158 | IGC50 | 4.309 |
LC50FM | -2.157 | LC50DM | 0.879 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.588 | NR-AR-LBD | 0.379 |
NR-AhR | 0.838 | NR-Aromatase | 0.204 |
NR-ER | 0.915 | NR-ER-LBD | 0.594 |
NR-PPAR-gamma | 0.9 | SR-ARE | 0.964 |
SR-ATAD5 | 0.904 | SR-HSE | 0.707 |
SR-MMP | 0.965 | SR-p53 | 0.946 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.